RSS-Feed abonnieren
DOI: 10.1055/s-2001-14503
Reizdarmsyndrom (RDS) - Was ist diagnostisch und therapeutisch möglich und nützlich ?
Irritable bowel syndrome: what is possible and helpful in its diagnosis and treatment?Publikationsverlauf
Publikationsdatum:
11. September 2002 (online)
![](https://www.thieme-connect.de/media/dmw/2001SupplGastroenterol1/lookinside/thumbnails/10.1055-s-2001-14503-1.jpg)
Vorbemerkung
Im Gegensatz zu organischen, meist gut definierten gastroenterologischen Krankheitsbildern, wie z. B. dem Ulkusleiden und Morbus Crohn, mit klar umschriebenen diagnostischen und therapeutischen Handlungsanweisungen sind die funktionellen gastroenterologischen Störungen und Erkrankungen jeweils als Ergebnis von krankhaft veränderten Funktionen ohne Nachweis von biochemischen und/oder morphologischen Veränderungen, besonders für die Diagnosesicherung und Behandlungsstrategie schwer fassbar.
Dies trifft im besonderen Maße für das Reizdarmsyndrom (RDS) zu. In den letzten Jahren wurden von verschiedenen Fachgesellschaften mehrere Leitlinien zum Management des RDS publiziert wie der »Technical Review on IBS« aus den USA [9], die Revision des Rom-I-Projektes »The functional gastrointestinal disorders Rome II« [7] sowie der Konsensusbericht der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) 1999 [18] und »Guidelines of the Management of IBS der britischen Society of Gastroenterology« [23] .
Die vorliegende Übersichtsarbeit basiert im Wesentlichen auf den vor 2 Jahren erarbeiteten deutschen Leitlinien der DGVS unter Berücksichtigung neuerer Publikationen innerhalb der letzten 2 Jahre.
Literatur
- 1 Agreus L, Svärdsudd K, Nyren O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology. 1995; 109 671-80
- 2 Allescher, HD, Adler G, Hartung J, Manns M P, Riemann J F, Wienbeck M, Classen M. Prospektive Epidemiologische Studie der Oberbauchschmerzen. DMW. 1999; 15 443
- 3 Bennett P, Wilkinson A. A comparsion of psychological and medical treatment of the irritable bowel syndrome. British J of Clin Psychology. 1985; 24 215-216
- 4 Bensoussan A, Talley N J, Hing M. et al . Treatment of irritable bowel syndrome with Chinese herbal medicine. A randomized controlled study. Jama. 1998; 280 1585-1589
- 5 CannPA, Read N W, Holdsworth C D, Barends D. Role of loperamide and placebo in management of irritable bowel syndrome. Dig Dis Sci. 1984; 29 239-247
- 6 Delvaux M, Denis P, Allemand H. and the French Club of Digestive Motility . Sexual abuse is more frequently reported by IBS patients than by patients with organic digestive disease or controls. Results of a multicentre inquiry. Eur J Gastroenterol Hepatol. 1996; 9 345-352
- 7 Drossman D A, Corazziari E, Talley N J, Thompson W G, Whitehead W E. Rome II- The functional gastrointestinal disorders. Diagnosis, Pathophysiology and Treatment: A multinational consensus. (Editors) Allen press, ENC, Lawrence, KS 2000 (Second Edition)
- 8 Drossman D A, Leserman J, Nachman G, Li Z, Gluck H, Toomey T C, Mitchell C M. Sexual and physical abuse in women with functional organic disorders. Ann Int Med. 1990; 113 828-833
- 9 Drossman D A, Li Z, Andruzzi E, Temple R D, Talley N J, Thompson W G, Whitehead W E, Janssens J, Funch-Jensen P. et al . U.S. householder survey on functional gastrointestinal disorders. Dig Dis Sci. 1993; 38 1569-1580
- 10 Drossman D A, Whitehead W E, Camilleri M. for the American Gastroenterological Association Patient Care Committee . Irritable bowel syndrome: A technical review for practice guideline development. Gastroenterology. 1997; 112 2102-2137
- 11 Edwards C A, Eastwood M A. Comparison of the effects of isphagula and wheat bran on rat caecal and colonic fermentation. Gut. 1992; 33 1229-1233
- 12 Enck P, Kremer A, Kuhlbusch R, Nierderau C, Erckenbrecht J F, Berges W. Prevalence of lactose malabsorption among patients with functional bowel disorders. Z Gastroenterol. 1990; 28 239-241
- 13 Enck P, Wienbeck M. Epidemiology and psychological factors of the irritable bowel syndrome. Europ J Gastroenterol Hepatol. 1993; 5 979-989
- 14 Francis C Y, Whorwell P J. Brain and irritable bowel syndrome: time for reappraisal. Lancet. 1994; 344 39-40
- 15 Guthrie E, Creed F, Dawson D, Tomenson B. A controlled trial of psychologiacal treatment for the irritable bowel syndrome. Gastroenterology. 1991; 100 450-457
- 16 Hamilton J W, Wagner J, Burdick B B, Bass P. Clinical evaluation of methylcellulose as a bulk laxative. Dig Dis Sci. 1988; 33 993-998
- 17 Holtmann G, Goebell H, Talley N J. Functional dyspepsia and irritable bowel syndrome: is there a common pathophysiological basis ?. Am J Gastroenterol. 1997; 92 954-959
- 18 Hotz J, Enck P, Goebell H, Heymann-Mönnikes I, Holtmann G, Layer P. Konsensusbericht: Reizdarmsyndrom. Definition, Diagnosesicherung, Pathophysiologie und Therapiemöglichkeiten. Konsensus der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten. Z Gastroenterol. 1999; 37 685-700
- 19 Madisch A, Holtmann G, Hotz J. et al . Benefit of a herbal preparation in patients with irritable bowel syndrome: results of a double-blind, randomized, placebo-controlled multicenter trial. Gastroenterology. 2000; 4 A4440
- 20 Hotz J, Plein K. Empfehlungen zur Therapie des Colon irritabile. Verdauungskrh. 1997; 15 196-199
- 21 Hotz J, Plein K. Wirkung von Plantago-Samenschalen im Vergleich zu Weizenkleie auf Stuhlfrequenz und Beschwerden beim Colon irritabile-Syndrom mit Obstipation. Med Klin. 1994; 89 645-651
- 22 Ivey K W. Are anticholinergics of use in the irritable colon syndrome?. Gastroenterol. 1975; 68 1300-1307
- 23 Jones J, Boorman J, Cann P, Forbes A, Gomborone J, Heaton K. et al . British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome. Gut. 2000; ii1-ii19 (Suppl II) 4)
- 24 Jones R, Lydeard S. Irritable bowel syndrome in the general population. BMJ. 1992; 304 87-90
- 25 Jones V A, MCLaughlan P, Shorthouse M, Workman E, Hunter J O. Food intolerance: a major factor in the pathogenesis of irritable bowel syndrome. Lancet. 1982; 2 1115-1117
- 26 Kellow J E, Phillips S F. Altered small bowel motility in irritable bowel syndrome is correlated with symptoms. Gastroenterology. 1987; 92 1885-1893
- 27 Klein K B. Controlled treatment trials in the irritable bowel syndrome: a critique. Gastroenterology. 1988; 95 232-241
- 28 Lémann M, Dederding J P, Flourie B, Franchisseur C, Rambaud J C, Jian R. Abnormal perception of visceral pain in response to gastric distension in gastric idiopathic dyspepsia. The irritable stomach syndrome. Dig Dis Sci. 1991; 36 1249-1254
- 29 Lembo T. Fiber and its effect on colonic function in health and disease. Current opinion in Gastroenterology. 1998; 14 1-5
- 30 Lynch P M, Zamble E A. A controlled behavioral treatment study of irritable bowel syndrome. Behavior Therapy. 1989; 509-523
- 31 Marteau P, Flourié B, Cherbut C, Corréze J L, Pellier P, Seylaz J, Rambaud J C. Digestibility and bulking effect of isphaghula husks in healthy humans. Gut. 1994; 35 1747-1752
- 32 McKendrick M W, Read N W. Irritable bowel syndrome - post salmonella infection. J Infect. 1994; 29 1-3
- 33 Neal K R, Hebden J, Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. Brit Med J. 1997; 314 779-82
- 34 Passaretti S, Tittobello A, Capozzi C, Verlinden M. Cisapride accelerates total intestinal transit in patients with irritable bowel syndrome-associated constipation. Progr Med. 1987; 43 121-129
- 35 Poynard T, Naveau S, Mory B, Chaput J C. Meta-analysis of smooth muscle relaxants in the treatment of irritbale bowel syndrome. Aliment Pharm Ther. 1994; 8 499-410
- 36 Richter J E, Barish C F, Castell D O. Abnormal sensory perception in patients with esophageal chest pain. Gastroenterology. 1986; 91 845-852
- 37 Van Outryve M, Milo R, Toussaint J. et al . »Prokinetc« treatment of constipation-predominant irritable bowel syndrome: a placebo-controlled study of cisapride. J Clin Gastroenterol. 1991; 13 49
- 38 Whitehead W E, Crowell M D, Robinson J C, Heller B R, Schuster M M. Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction. Gut. 1992; 33 825-830
- 39 Whitehead W E, Holtkoetter B, Enck P, Hoelzl R, Holmes K D, Anthony J, Shabsin H S, Schuster M M. Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenterology. 1990; 98 1187-1192
- 40 Zwetschenbaum J F, Burakoff R. Food allergy and the irritable bowel syndrome. Am J Gastroenterol. 1988; 83 901-904
Korrespondenz
Prof. Dr. med. J. Hotz
Klinik für Gastroenterologie Allgemeines
Krankenhaus Celle
Siemensplatz 4
29223 Celle
Telefon: 05141/721201
Fax: 05141/721209
eMail: gastroenterologie@akh-celle.de